Referenser

  1. Phillips JD. Heme biosynthesis and the porphyrias. Mol Genet Metab. 2019;128(3):164-77.

  2. Harper P, Sardh E. Management of acute intermittent porphyria. Expert Opinion on Orphan Drugs. 2014;2(4):349-68.

  3. Andersson C, Innala E, Bäckström T. Acute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones. A population-based study in northern Sweden. J Intern Med. 2003;254(2):176-83.

  4. Bylesjö I, Wikberg A, Andersson C. Clinical aspects of acute intermittent porphyria in northern Sweden: a population-based study. Scand J Clin Lab Invest. 2009;69(5):612-8.

  5. Theodorsson E, Berggren Söderlund M. Laurells Klinisk kemi i praktisk medicin. Studentlitteratur AB; 2018. p. 650-5.

  6. Anderson KE. Acute hepatic porphyrias: Current diagnosis & management. Mol Genet Metab. 2019;128(3):219-27.

  7. Balwani M, Sardh E, Ventura P, Peiró PA, Rees DC, Stölzel U, et al. Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria. N Engl J Med. 2020;382(24):2289-301.

  8. Lissing M, Nowak G, Adam R, Karam V, Boyd A, Gouya L, et al. Liver Transplantation for Acute Intermittent Porphyria. Liver Transpl. 2021;27(4):491-501.

  9. Mantel Ä, Vassiliou D, Lissing M, Stephansson O, Wahlin S, Sardh E. Maternal and fetal outcomes in acute hepatic porphyria: A Swedish National Cohort Study. J Inherit Metab Dis. 2023;46(4):675-86.

  10. Vassiliou D, Lindén Hirschberg A, Sardh E. Treatment with assisted reproduction technologies in women with acute hepatic porphyria. Acta Obstet Gynecol Scand. 2021;100(9):1712-21.

  11. Innala E, Andersson C. Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. J Intern Med. 2011;269(5):538-45.

  12. Lissing M, Vassiliou D, Floderus Y, Harper P, Bottai M, Kotopouli M, et al. Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals. J Intern Med. 2022;291(6):824-36.

  13. Regionala cancercentrum. Levercellscancer. Nationellt vårdprogram [Internet]. 2022. Available from: https://kunskapsbanken.cancercentrum.se/globalassets/cancerdiagnoser/lever-och-galla/vardprogram/nationellt-vardprogram-levercellscancer.pdf

  14. Singal AK. Porphyria cutanea tarda: Recent update. Mol Genet Metab. 2019;128(3):271-81.

  15. Balwani M. Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management. Mol Genet Metab. 2019;128(3):298-303.

Föregående sida
För vidare läsning

Nästa sida
Tillbaka till kapitlets första sida